Haleon plc (NYSE:HLN) Shares Purchased by Procyon Advisors LLC

Procyon Advisors LLC raised its holdings in Haleon plc (NYSE:HLN) by 41.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 230,240 shares of the company’s stock after acquiring an additional 67,329 shares during the quarter. Procyon Advisors LLC’s holdings in Haleon were worth $2,196,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. HighTower Advisors LLC increased its holdings in shares of Haleon by 27.2% in the 3rd quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after purchasing an additional 74,970 shares in the last quarter. Jane Street Group LLC increased its holdings in Haleon by 1,689.4% in the third quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock valued at $2,803,000 after buying an additional 250,169 shares in the last quarter. Chartwell Investment Partners LLC lifted its position in shares of Haleon by 107.8% during the 3rd quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock valued at $5,030,000 after acquiring an additional 246,594 shares during the period. Townsquare Capital LLC boosted its stake in shares of Haleon by 29.8% during the 3rd quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock worth $5,032,000 after acquiring an additional 109,217 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in shares of Haleon by 25.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company’s stock worth $53,791,000 after acquiring an additional 1,026,939 shares during the period. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Price Performance

HLN stock opened at $9.24 on Friday. The stock’s 50 day moving average price is $9.54 and its 200 day moving average price is $9.69. The firm has a market cap of $41.80 billion, a P/E ratio of 27.16, a PEG ratio of 2.52 and a beta of 0.29. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HLN. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. UBS Group raised Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st. Finally, Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.